Protein-based therapeutics are an attractive alternative to established therapeutic
approaches and represent one of the fastest growing families of drugs. While many of these …

The use of nanoparticulate pharmaceutical drug delivery systems (NDDSs) to enhance the
in vivo effectiveness of drugs is now well established. The development of multifunctional …

The use of liposomes for drug delivery began early in the history of pharmaceutical
nanocarriers. These nanosized, lipid bilayered vesicles have become popular as drug …

Nanocarriers have revolutionized drug delivery practices over the past couple of decades,
primarily due to the advances in materials chemistry, nanotechnology and nanomedicine …

Liposomal delivery systems have significantly enhanced the efficacy and safety of
chemotherapeutic agents compared to free (non-liposomal) formulations. Liposomes are …

Clinically efficacious medication in anticancer therapy has been successfully designed with
liposome-based nanomedicine. The liposomal formulation in cancer drug delivery can be …

With ever increasing scientific knowledge and awareness, research is underway around the
globe to design new types of stimuli (external/internal) responsive nano-carriers for …

Pharmaceutical nanotechnology introduces novel strategies in designing smart nanoscale
drug delivery systems (NDDSs) capable of responding to specific conditions. These smart …

Liposomes are delivery systems that have been used to formulate a vast variety of
therapeutic and imaging agents for the past several decades. They have significant …

Nanocapsules composed of a poly (vinylferrocene)-block-poly (methyl methacrylate) shell
and a hydrophobic liquid core are prepared in water. The nanocapsule shells display a …